Advertisement
ARQT vs PTCT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a Hold and PTCT is a Hold.
ARQT in downward trend: 10-day moving average broke below 50-day moving average on October 13, 2026
The 10-day moving average for ARQT crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARQT as a result. In 74 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARQT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for ARQT entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ARQT just turned positive on October 13, 2026. Looking at past instances where ARQT's MACD turned positive, the stock continued to rise in 37 of 45 cases over the following month. The odds of a continued upward trend are 82%.
ARQT moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARQT advanced for three days, in 249 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
ARQT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ARQT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARQT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.576) is normal, around the industry mean (26.782). P/E Ratio (124.227) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (7.435) is also within normal values, averaging (437.542).
PTCT sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for PTCT moved below the 200-day moving average on September 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTCT as a result. In 66 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for PTCT turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 30 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for PTCT entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTCT's RSI Oscillator exited the oversold zone, 22 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in 225 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
PTCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. PTCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PTCT's P/B Ratio (1666.670) is very high in comparison to the industry average of (26.782). P/E Ratio (7.508) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (6.094) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ARQT | PTCT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 87 | 69 | |
SMR RATING 1..100 | 54 | 100 | |
PRICE GROWTH RATING 1..100 | 44 | 75 | |
P/E GROWTH RATING 1..100 | 34 | 30 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ARQT's Valuation (92) in the null industry is in the same range as PTCT (99) in the Biotechnology industry. This means that ARQT’s stock grew similarly to PTCT’s over the last 12 months.
PTCT's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as ARQT (87) in the null industry. This means that PTCT’s stock grew similarly to ARQT’s over the last 12 months.
ARQT's SMR Rating (54) in the null industry is somewhat better than the same rating for PTCT (100) in the Biotechnology industry. This means that ARQT’s stock grew somewhat faster than PTCT’s over the last 12 months.
ARQT's Price Growth Rating (44) in the null industry is in the same range as PTCT (75) in the Biotechnology industry. This means that ARQT’s stock grew similarly to PTCT’s over the last 12 months.
PTCT's P/E Growth Rating (30) in the Biotechnology industry is in the same range as ARQT (34) in the null industry. This means that PTCT’s stock grew similarly to ARQT’s over the last 12 months.
| ARQT | PTCT | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 82% | 1 day ago 68% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 76% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 75% |
| Advances ODDS (%) | 6 days ago 85% | 9 days ago 80% |
| Declines ODDS (%) | 2 days ago 87% | 1 day ago 78% |
| BollingerBands ODDS (%) | 1 day ago 81% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARQT’s FA Score shows that 0 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).
- ARQT’s FA Score: 0 green, 5 red.
- PTCT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARQT’s TA Score shows that 4 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).
- ARQT’s TA Score: 4 bullish, 5 bearish.
- PTCT’s TA Score: 4 bullish, 5 bearish.
Price Growth
ARQT (@Biotechnology) experienced а +9.27% price change this week, while PTCT (@Biotechnology) price change was -5.63% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -8.52%. For the same industry, the average monthly price growth was -19.04%, and the average quarterly price growth was -19.99%.
Reported Earning Dates
ARQT is expected to report earnings on Oct 29, 2026.
PTCT is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Biotechnology (-8.52% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TFJL | 18.70 | 0.11 | +0.61% |
| Innovator 20 Year Treasury Bond 5 Floor ETF | |||
| FMED | 30.64 | 0.14 | +0.46% |
| Fidelity Disruptive Medicine ETF (FMED) | |||
| SCHK | 36.93 | -0.44 | -1.18% |
| Schwab 1000 Index ETF (SCHK) | |||
| IXP | 117.42 | -1.83 | -1.53% |
| iShares Global Comm Services ETF (IXP) | |||
| EMXF | 55.45 | -1.12 | -1.98% |
| iShares ESG Advanced MSCI EM ETF (EMXF) | |||